申请人:DU PONT PHARM CO
公开号:WO2002000651A2
公开(公告)日:2002-01-03
This invention relates generally to compounds of formula (Ia) or (Ia) (Ib) that are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.